
Ugspas C 2.5mg/5mg/10mg Tablet
Marketer
Euphony Healthcare
Salt Composition
Clidinium (2.5mg) + Chlordiazepoxide (5mg) + Dicyclomine (10mg)
Overview Ugspas C 2.5mg/5mg/10mg Tablet
Relpax tablets (2.5mg/5mg/10mg) offer relief from irritable bowel syndrome, addressing symptoms such as abdominal pain, cramping, bloating, and altered bowel habits (diarrhea or constipation). This medication works by preventing sudden muscle spasms in the gut, alleviating pain and cramping, and facilitating gas expulsion to ease discomfort. Relpax tablets should be taken on an empty stomach, following your doctor's prescribed dosage and duration. The correct dose depends on your individual needs and response. Continue treatment as directed; premature discontinuation may lead to symptom recurrence and worsening of your condition. Inform your physician of all other medications you are using, as interactions are possible. Common side effects include nausea, constipation, anxiety, dry mouth, urinary difficulties, confusion, weakness, blurred vision, and impaired coordination. Most side effects are transient. Report any concerning side effects immediately. Drowsiness and dizziness may occur; avoid driving or activities requiring alertness until you understand the medication's effects on you. Refrain from alcohol consumption while using this medication due to increased drowsiness risk. A balanced diet rich in fiber, avoidance of trigger foods, increased hydration, and regular exercise can enhance treatment outcomes. Before commencing treatment, inform your doctor of any kidney or liver conditions, and if you are pregnant, planning pregnancy, or breastfeeding.
Primary Ingredients of Ugspas C 2.5mg/5mg/10mg Tablet
The provided text is "undefined," therefore no rewriting is possible.
Uses of Ugspas C 2.5mg/5mg/10mg Tablet
Managing irritable bowel syndrome
Major Benefits of Ugspas C 2.5mg/5mg/10mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Ugspas C 2.5mg/5mg/10mg Tablets should be taken on an empty stomach.
Common Side effects of Ugspas C 2.5mg/5mg/10mg Tablet:
- Nausea
- Constipation
- Nervousness
- Dryness in mouth
- Difficulty in urination
- Confusion
- Sleepiness
- Weakness
- Dizziness
- Blurred vision
- Impaired coordination
How to use Ugspas C 2.5mg/5mg/10mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the Ugspas C 2.5mg/5mg/10mg tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication on an empty stomach.
How Ugspas C 2.5mg/5mg/10mg Tablet works:
Tri-Med Formula C (2.5mg/5mg/10mg) tablets combine clidinium, chlordiazepoxide, and dicyclomine to alleviate gastrointestinal distress. Clidinium and dicyclomine, antispasmodic agents, reduce intestinal muscle spasms, thereby easing cramping, pain, bloating, and discomfort. Chlordiazepoxide, a benzodiazepine, enhances GABA neurotransmission, modulating heightened neuronal activity in the brain.
SAFETY ADVICE
AlcoholUNSAFE
Combining Ugspas C 2.5mg/5mg/10mg tablets with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Using Ugspas C tablets (2.5mg/5mg/10mg) during pregnancy poses a confirmed risk to the fetus. Prescribing may occur exceptionally in life-threatening cases where potential benefits outweigh the known dangers. Physician consultation is essential.
Breast feedingCONSULT YOUR DOCTOR
The use of Ugspas C 2.5mg/5mg/10mg tablets while breastfeeding is likely inadvisable. Preliminary evidence from human studies indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by Ugspas C 2.5mg/5mg/10mg Tablets, due to potential drowsiness or concentration difficulties induced by the medication.
KidneyCAUTION
Patients with impaired kidney function should use Ugspas C tablets (2.5mg/5mg/10mg) cautiously. Dosage modification may be necessary; physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Ugspas C tablets (2.5mg, 5mg, and 10mg strengths) cautiously. Dosage modification may be necessary; physician consultation is advised.
What if you forget to take Ugspas C 2.5mg/5mg/10mg Tablet :
Should you forget to take your Ugspas C 2.5mg/5mg/10mg Tablet, administer it immediately upon remembrance. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Ugspas C 2.5mg/5mg/10mg Tablet
| Label | Value |
|---|---|
| Developing Habits | Affirmative. |
| Type of Therapy | Gastrointestinal system |
